Premenstrual Syndrome — Pathophysiologic Considerations
- 22 January 1998
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (4) , 256-257
- https://doi.org/10.1056/nejm199801223380409
Abstract
During the past decade premenstrual syndrome has become a well-defined entity.1 The hallmark of the syndrome is the repeated occurrence of behavioral and somatic symptoms severe enough to impair a woman's social and work-related functioning during the luteal phase of the menstrual cycle. On the basis of strict diagnostic criteria, the prevalence of the disorder is estimated to be 2.5 percent among women of reproductive age. No marked racial or ethnic differences in the prevalence of the disorder have been identified.There are several effective treatments for premenstrual syndrome that have largely supplanted older, unproved therapies such as dietary restrictions, . . .Keywords
This publication has 8 references indexed in Scilit:
- Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual SyndromeNew England Journal of Medicine, 1998
- Gonadotropin-releasing hormone agonists: Strategies formanaging the hypoestrogenic effects of therapyAmerican Journal of Obstetrics and Gynecology, 1992
- Successful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin-Releasing Hormone Agonist and Estrogen/Progestin*Journal of Clinical Endocrinology & Metabolism, 1991
- Ineffectiveness of progesterone suppository treatment for premenstrual syndromePublished by American Medical Association (AMA) ,1990
- Depressive episodes in premenstrual syndromeAmerican Journal of Obstetrics and Gynecology, 1989
- Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA ReceptorScience, 1986
- The Premenstrual SyndromeNew England Journal of Medicine, 1984
- Serotonin receptor concentration during the estrous cycle of the ratBrain Research, 1980